Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $1.8 million.

  • Haemonetics' Change in Taxes rose 26595.35% to $1.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.2 million, marking a year-over-year decrease of 17878.9%. This contributed to the annual value of -$226000.0 for FY2025, which is 12299.08% down from last year.
  • Latest data reveals that Haemonetics reported Change in Taxes of $1.8 million as of Q4 2025, which was up 26595.35% from $210000.0 recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Change in Taxes ranged from a high of $6.9 million in Q3 2024 and a low of -$3.3 million during Q2 2025
  • Over the past 5 years, Haemonetics' median Change in Taxes value was -$191500.0 (recorded in 2021), while the average stood at -$7500.0.
  • Within the past 5 years, the most significant YoY rise in Haemonetics' Change in Taxes was 936296.3% (2023), while the steepest drop was 160628.57% (2023).
  • Over the past 5 years, Haemonetics' Change in Taxes (Quarter) stood at -$356000.0 in 2021, then soared by 149.16% to $175000.0 in 2022, then crashed by 1606.29% to -$2.6 million in 2023, then soared by 59.22% to -$1.1 million in 2024, then skyrocketed by 265.95% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q4 2025, $210000.0 for Q3 2025, and -$3.3 million during Q2 2025.